MTOR and Middle East respiratory syndrome: Prior studies have reported that combining an mTOR inhibitor with hormones and antiviral drugs improves clinical outcomes, such as hypoxemia and multi-organ failure, in the treatment of Middle East respiratory syndrome and severe influenza [14, 33, 34].